RECRUITING

Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis

Description

This study is designed to investigate whether non-invasive ultrasound (US) that is optimized for stimulation and can elicit an anti-inflammatory response in people with Inflammatory Arthritis as compared to a sham intervention. The primary endpoint is the change in pro-inflammatory cytokines in blood drawn before and after US. Each participant receives 4 experimental US sessions, one of which is randomly assigned to be placebo.

Conditions

Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis
Talk to us

Related Conditions:

Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis

Study Overview

On this page

Study Details

Study overview

This study is designed to investigate whether non-invasive ultrasound (US) that is optimized for stimulation and can elicit an anti-inflammatory response in people with Inflammatory Arthritis as compared to a sham intervention. The primary endpoint is the change in pro-inflammatory cytokines in blood drawn before and after US. Each participant receives 4 experimental US sessions, one of which is randomly assigned to be placebo.

Activating the Cholinergic Anti-Inflammatory Pathway With Focused Ultrasound Stimulation in Healthy Volunteers and People With Inflammatory Arthritis

Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis

Condition
Psoriatic Arthritis
Intervention / Treatment

-

Contacts and Locations

Austin

Tekton Research, Austin, Texas, United States, 78745

Houston

UT Health, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 22-75 years of age
  • * Weigh at least 40 kg
  • * Any physical disabilities, conditions, or diseases that limit the capacity to participate in study procedures or increase the risk of harm as determined by the study PI
  • * Unable to provide informed consent
  • * Active bacterial or viral infection
  • * Class II obesity with a BMI of 35 or higher
  • * Pregnant women or those trying to become pregnant
  • * Active use of tobacco/nicotine products
  • * History of substance use disorder or active regular use of substances (nicotine, marijuana, cocaine, psychedelics, stimulants, etc.)
  • * Splenomegaly, asplenia, or splenectomy

Ages Eligible for Study

22 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Surf Therapeutics,

Study Record Dates

2027-10